Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

By sjmartinez • April 11, 2023

Pavord ID, Deniz Y, Corren J, Casale TB, FitzGerald JM, Izuhara K, Daizadeh N, Ortiz B, Johnson RR, Harel S, Djandji M, Goga L, Crikelair N, Rowe PJ, Busse WW. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1213-1220.e2. doi: 10.1016/j.jaip.2022.11.043. Epub 2022 Dec 16. PMID: 36535524.

Tags: Allergy & Immunology, asthma, Dupilumab, FEV(1), Fractional exhaled nitric oxide, Predictive biomarker, Publications, Severe exacerbations

Leveraging Learning Systems to Improve Quality and Patient Safety in Allergen Immunotherapy

Conway AE, Rupprecht C, Bansal P, Yuan I, Wang Z, Shaker MS, Verdi M, Bradley J. Leveraging Learning Systems to Improve Quality and Patient Safety[...]

APDS patients with immune-complex vasculitis and resolution with leniolisib

Dorodouchi MA, Stephens AV, Wang Z, Dhami J, Butte MJ. APDS patients with immune-complex vasculitis and resolution with leniolisib. Clin Immunol. 2024 Mar 8:110176. doi:[...]

Year 2. October 9. Celebrating Our Commitment to Health Equity.

Throughout Southern California, department of medicine (DoM) faculty are providing essential medical care to communities in high need. You may find faculty at community hospital[...]